enVVeno Medical Corporation (NVNO)
USD 2.57
(-7.89%)
USD 2.57
(-7.89%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -18.85 Million | -15.61 Million | -11.84 Million | -7.67 Million | -5.89 Million | -6.35 Million |
| Net Income | -23.51 Million | -24.66 Million | -16.52 Million | -9.13 Million | -7.62 Million | -13.04 Million |
| Depreciation & Amortization | 546 Thousand | 525 Thousand | 452.9 Thousand | 383.97 Thousand | 396.66 Thousand | 133.41 Thousand |
| Deferred income taxes | 221 Thousand | - | -312.7 Thousand | -184 Thousand | 588.82 Thousand | -1.35 Million |
| Stock-based compensation | 5.19 Million | 8.99 Million | 5.99 Million | 881.21 Thousand | 941.96 Thousand | 1.92 Million |
| Change in working capital | -616 Thousand | -130 Thousand | -1.14 Million | 665.78 Thousand | 66.78 Thousand | -578.4 Thousand |
| Other non-cash items | -689 Thousand | -339 Thousand | -312.61 Thousand | -288.68 Thousand | -265.24 Thousand | 6.56 Million |
| Investing Cash Flow | -7.86 Million | -34.55 Million | -367.89 Thousand | -180.29 Thousand | -363.89 Thousand | -12.42 Thousand |
| Investments in PPE | -33 Thousand | -115 Thousand | -367.89 Thousand | -180.29 Thousand | -363.89 Thousand | -12.42 Thousand |
| Acquisitions | 7835.00 | 34.43 Thousand | - | - | - | - |
| Investment purchases | -56.52 Million | -48.12 Million | - | - | - | - |
| Sales/Maturities of investments | 48.68 Million | 13.68 Million | - | - | - | - |
| Other Investing Activities | -7835.00 | -34.43 Thousand | - | - | - | - |
| Financing Cash Flow | 25.79 Million | - | 57.6 Million | 15.07 Million | 5.63 Million | 9.03 Million |
| Debt repayment | - | - | - | -312.7 Thousand | - | -1.24 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 25.79 Million | - | 57.6 Million | 10.41 Million | 5.63 Million | 7.65 Million |
| Other Financing Activities | 25.79 Million | - | 57.6 Thousand | 4.96 Million | 5636.93 | 2.61 Million |
| Accounts receivables | - | - | - | - | 32.02 Thousand | 3159.00 |
| Accounts payables | -221 Thousand | 88 Thousand | -832.7 Thousand | 169.17 Thousand | 144.06 Thousand | -294.12 Thousand |
| Inventory | - | - | - | - | - | -217.03 Thousand |
| Other working capital | -395 Thousand | -218 Thousand | -312.09 Thousand | 496.6 Thousand | -109.3 Thousand | -70.4 Thousand |
| Cash at beginning of period | 4.55 Million | 54.72 Million | 9.33 Million | 2.11 Million | 2.74 Million | 77.68 Thousand |
| Cash at end of period | 3.62 Million | 4.55 Million | 54.72 Million | 9.33 Million | 2.11 Million | 2.74 Million |
| Capital Expenditure | -33 Thousand | -115 Thousand | -367.89 Thousand | -180.29 Thousand | -363.89 Thousand | -12.42 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -935 Thousand | -50.17 Million | 45.39 Million | 7.21 Million | -623.35 Thousand | 2.66 Million |
| Free Cash Flow | -18.89 Million | -15.73 Million | -12.21 Million | -7.85 Million | -6.26 Million | -6.36 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.43 Million | -4.95 Million | -4.99 Million | -5.64 Million | -23.51 Million | -5 Million |
| Depreciation & Amortization | 194.82 Thousand | 136 Thousand | 141 Thousand | 134 Thousand | 546 Thousand | 138 Thousand |
| Deferred income taxes | - | - | - | 5.14 Million | 221 Thousand | 2.05 Million |
| Stock-based compensation | 2.79 Million | 1 Million | 1.11 Million | 1.14 Million | 5.19 Million | 1.1 Million |
| Change in working capital | 1.9 Million | -46 Thousand | 230 Thousand | -701 Thousand | -616 Thousand | -297 Thousand |
| Other non-cash items | 328 Thousand | 1.06 Million | 1.24 Million | -5.04 Million | -689 Thousand | -2.21 Million |
| Investing Cash Flow | 12.54 Million | 3.97 Million | 2.19 Million | -22.14 Million | -7.86 Million | 4.44 Million |
| Investments in PPE | 117.5 Thousand | -14 Thousand | -10 Thousand | -4000.00 | -33 Thousand | -3000.00 |
| Acquisitions | - | - | - | 14.3 Thousand | 7835.00 | -4448.00 |
| Investment purchases | -33.42 Million | -9.93 Million | -15.13 Million | -32.24 Million | -56.52 Million | -9.17 Million |
| Sales/Maturities of investments | 45.84 Million | 13.92 Million | 17.34 Million | 10.1 Million | 48.68 Million | 13.62 Million |
| Other Investing Activities | - | 3.98 Million | 2.2 Million | -14.3 Thousand | -7835.00 | 4448.00 |
| Financing Cash Flow | -24.73 Million | - | 46 Thousand | 25.79 Million | 25.79 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -38.12 Million | - | 46 Thousand | 25.79 Million | 25.79 Million | - |
| Other Financing Activities | 13.39 Million | - | 46 Thousand | 25.79 Million | 25.79 Million | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.92 Million | 161 Thousand | 110 Thousand | -705 Thousand | -221 Thousand | -172 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 820.44 Thousand | -247 Thousand | 120 Thousand | 4000.00 | -395 Thousand | -125 Thousand |
| Cash at beginning of period | 41.03 Million | 2.31 Million | 3.62 Million | 4.94 Million | 4.55 Million | 4.71 Million |
| Cash at end of period | 17.91 Million | 2.38 Million | 2.31 Million | 3.62 Million | 3.62 Million | 4.94 Million |
| Capital Expenditure | 117.5 Thousand | -14 Thousand | -10 Thousand | -4000.00 | -33 Thousand | -3000.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -23.12 Million | 66 Thousand | -1.3 Million | -1.32 Million | -935 Thousand | 232 Thousand |
| Free Cash Flow | -5.1 Million | -3.92 Million | -3.55 Million | -4.97 Million | -18.89 Million | -4.21 Million |
GRN
301020
NNVC
MANN
IPU
0QLQ